use of chymase inhibitors for the treatment of endometriosis, postoperative fibrosis and disorders that are characterized by fibrosis

摘要

this application relates to the use of bicyclic substituted uracil derivatives, separately or in combination with other active ingredients for the treatment and / or prophylaxis of diseases, in particular, for the treatment and / or prophylaxis of inflammatory and fibrotic disorders, for the treatment of endometriosis, fibrosis associated with endometriosis, adenomyosis and pain associated with an endometriosis disorder and also of postoperative peritoneal fibrosis and adhesion formation.